Ignite Creation Date:
2025-12-24 @ 2:44 PM
Ignite Modification Date:
2026-01-24 @ 8:50 AM
Study NCT ID:
NCT05559359
Status:
RECRUITING
Last Update Posted:
2025-12-09
First Post:
2022-09-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Eli Lilly and Company
Organization: